Advances in targeting cancer-associated fibroblasts through single-cell spatial transcriptomic sequencing.

Area of Science:

• Oncology
• Molecular Biology
• Bioinformatics

Background:

• Cancer-associated fibroblasts (CAFs) are key players in the tumor microenvironment, influencing tumor progression, metastasis, and treatment resistance.
• Single-cell RNA sequencing (scRNA-seq) is crucial for identifying CAFs but lacks spatial context.
• Existing methods struggle to map CAF distribution within the tumor microenvironment.

Purpose of the Study:

• To review recent advancements in understanding CAFs using integrated multiomics approaches.
• To highlight how spatial transcriptomics combined with scRNA-seq addresses the limitations of CAF analysis.
• To summarize therapeutic strategies targeting CAFs for various cancer hallmarks.

Main Methods:

• Review of recent literature on CAFs and tumor microenvironment research.
• Integration of single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics.
• Multiomics analyses to achieve single-cell resolution in spatial data.

Main Results:

• Spatial transcriptomics combined with scRNA-seq provides a detailed spatial landscape of CAFs.
• These integrated approaches resolve single-cell resolution challenges in spatial transcriptomics.
• Targeting CAFs shows promise in overcoming drug resistance, angiogenesis, metabolic reprogramming, and metastasis.

Conclusions:

• Integrated multiomics analyses, particularly spatial transcriptomics with scRNA-seq, are revolutionizing CAF research.
• Understanding the spatial context of CAFs is critical for developing effective cancer therapies.
• Targeting CAFs presents a promising avenue for improving patient outcomes in various cancers.